• Home
  • Store
    • Total Access Subscriptions
    • Newsletter Subscriptions
    • Multimedia
    • Books
    • eBooks
    • ABPN SA Courses
    • Institutional Site Licenses
  • CME Center
  • Multimedia
    • Podcast
    • Webinars
    • Blog
  • Newsletters
    • General Psychiatry
    • Child Psychiatry
    • Addiction Treatment
    • Hospital Psychiatry
    • Geriatric Psychiatry
    • Psychotherapy and Social Work
  • Toolkit
  • FAQs
  • Log In
  • Register
  • Welcome
  • Sign Out
  • Subscribe
Access Purchased Content
Home » Authors » Joshua Feder, MD
Joshua Feder, MD

Joshua Feder, MD

Editor-in-Chief,
Articles
Products

ARTICLES

canstockphoto33982948.jpg

Treating Irritability in Autistic Children: Functional and Medication Approaches

April 24, 2023
Joshua Feder, MD and Mara Goverman

Antipsychotics can be very effective for irritability in autism, but they are often unnecessary, and the side effects are truly problematic. Don’t be the prescriber who hears irritability in autism and immediately prescribes antipsychotics. There are usually multiple steps to try before using the FDA-approved antipsychotic medications.


Read More
canstockphoto29377983.jpg

Anxiolytics in Children and Adolescents

April 17, 2023
Joshua Feder, MD and Mara Goverman

Learn about the pros and cons of the main categories of medications that clinicians typically use to treat anxiety in children and adolescents.


Read More
Clinical Update

Treating Irritability in Autism: Functional and Medication Approaches

April 1, 2023
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Editorial Information | PDF of Issue

Joshua D. Feder, MD. Editor-in-Chief, The Carlat Child Psychiatry Report.

Dr. Feder has no financial relationships with companies related to this material.

Antipsychotics can be very effective for irritability in autism, but they are often unnecessary, and the side effects are truly problematic. Don’t be the prescriber who hears irritability in autism and immediate prescribes antipsychotics. There are usually multiple steps to try before using the FDA approved antipsychotic medications.


Read More
teen_depression.jpeg

Assessment of Non-Suicidal Self-Injury in Children and Adolescents

March 12, 2023
Joshua Feder, MD, Mara Goverman, and Hanni Flaherty, LCSWR, PhD, CASAC

Learn how to assess and intervene with NSSI, including ideas for supporting autonomy while addressing the behavior.


Read More
canstockphoto31888230.jpg

Addressing Sensory Processing Challenges

February 12, 2023
Joshua Feder, MD and Mara Goverman

Learn to identify sensory challenges to address these barriers to effective care in teens and adolescents.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023)

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More

Child Medication Fact Book for Psychiatric Practice, Second Edition (2023).

PDF Access and 10 CME Post-Test
January 20, 2023
Joshua Feder, MD, Elizabeth Tien, MD, and Talia Puzantian, PharmD, BCPP

This page has links and instructions for downloading your PDF and eBook copies of the Child Medication Fact Book for Psychiatric Practice and completing the 10 CME Post-Test.


Read More
RESEARCH UPDATE

SSRIs and Hydroxyzine for Avoidant/Restrictive Food Intake Disorder (ARFID)?

October 1, 2022
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

Dr. Feder, author of this educational activity, has no relevant financial relationship(s) with ineligible companies to disclose.

Clinicians use olanzapine, mirtazapine, and other appetite-inducing medications off label to treat ARFID, but with little research to support their use. This study unpacks the potential role of medications in treating comorbid symptoms associated with ARFID. 


Read More

Note from the Editor-in-Chief

July 1, 2022
Joshua Feder, MD
From The Carlat Child Psychiatry Report
Issue Links: Learning Objectives | Editorial Information | PDF of Issue

New editor-in-chief of the Carlat Child Psychiatry Report. Dr. FederJosh Feder, MD.

Editor-in-Chief of The Carlat Child Psychiatry Report.

In 2015 at my first Graphic Medicine conference (www.graphicmedicine.org), clinicians and patients spoke about the daily hurt people experience with fat shaming, some to the point of suicidality. It’s one thing to see it but another to fight it. Our interview with Dr. Sarah Nutter helps us combat weight bias. 


Read More
View All Articles by Joshua Feder, MD
Try The New AskCarlat AI

Ask any clinical question—our AI responds using only the peer-reviewed, editorially vetted content from Carlat Publishing.

Available In The Carlat Toolkit
Free Psychiatry Updates
The latest unbiased psychiatric information sent to your inbox.
Specify Your Interests
Featured Book
  • MFB8e_SpiralCover.png

    Medication Fact Book for Psychiatric Practice, Eighth Edition (2026)

    Updated 2026 prescriber's guide.
    READ MORE
Featured Video
  • KarXT (Cobenfy)_ The Breakthrough Antipsychotic That Could Change Everything.jpg
    General Psychiatry

    KarXT (Cobenfy): The Breakthrough Antipsychotic That Could Change Everything

    Read More
Featured Podcast
  • shutterstock_2428554093.jpg
    Psychology and Social Work

    CBT-I: The First-Line Treatment for Chronic Insomnia with Dr. Donn Posner (Part 2 of 2)

    Dr. Donn Posner is a leading expert in cognitive behavioral therapy for insomnia (CBT-I) and one of the field's most active educators.


    Listen now
Recommended
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png
  • Join Our Writing Team

    July 18, 2024
    WriteForUs.png
  • Insights About a Rare Transmissible Form of Alzheimer's Disease

    February 9, 2024
    shutterstock_2417738561_PeopleImages.com_Yuri A.png
  • How to Fulfill the DEA's One Time, 8-Hour Training Requirement for Registered Practitioners

    May 24, 2024
    DEA_Checkbox.png

About

  • About Us
  • CME Center
  • FAQ
  • Contact Us

Shop Online

  • Newsletters
  • Multimedia Subscriptions
  • Books
  • eBooks
  • ABPN Self-Assessment Courses

Newsletters

  • The Carlat Psychiatry Report
  • The Carlat Child Psychiatry Report
  • The Carlat Addiction Treatment Report
  • The Carlat Hospital Psychiatry Report
  • The Carlat Geriatric Psychiatry Report
  • The Carlat Psychotherapy Report

Contact

carlat@thecarlatreport.com

866-348-9279

PO Box 626, Newburyport MA 01950

Follow Us

Please see our Terms and Conditions, Privacy Policy, Subscription Agreement, Use of Cookies, and Hardware/Software Requirements to view our website.

© 2026 Carlat Publishing, LLC and Affiliates, All Rights Reserved.